Applied Therapeutics (APLT) ROE US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -114.7% | -168.8% | -2 032% | 698.5% | -185.3% | 3 233% | ||
| Changes by years, y/y, % | +25pp | -54pp | -1 863pp | +2 730pp | -884pp | +5.9% | |||
Applied Therapeutics. ROE, %
Applied Therapeutics. ROE, changes, pp
Applied Therapeutics (APLT) ROE US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | LTM ? | |||
| ROE, % | ? | -3 179% | -76.3% | -118.7% | -388.5% | 3 233% | 3 233% | |
| Changes by years, y/y, % | -4 053pp | -775pp | +169pp | -166pp | +6 412pp | |||
| Changes by quarters, q/q, % | -2 957pp | +3 103pp | -42pp | -270pp | +3 622pp | |||